A lawyer for two Ohio counties said CVS Health Corp., Walgreens Boots Alliance Inc. and Walmart Inc. should fund an $878 million plan to address the opioid crisis there, as a first-of-its-kind trial got underway to determine the pharmacy chains’ contribution.
Opioid distributors reach $518 million settlement with Washington stateAllegations, AmerisourceBergen, Business, Cardinal Health, Class Action Lawsuits, Drug Distributors, Epidemics, Hydrocodone, Johnson & Johnson, Lawsuits, Legal, McKesson, Opioid Epidemic, Opioid Overdoses, Opioids, Opioids, Settlements, Therapeutics, U.S. Centers for Disease Control and Prevention, Washington
Washington reached a $518 million settlement with drug distributors McKesson Corp., AmerisourceBergen Corp. and Cardinal Health, ending a months-long trial over the companies’ alleged role in fueling the opioid epidemic in the state, the three companies announced on May 3.
Tennessee Court of Appeals Orders Recusal of Trial Court Judge and Vacates Default Judgment on Liability Against EndoBusiness, Class Action Lawsuits, Endo, Lawsuits, Litigation, Opioid Litigation, Opioid Litigation, Opioid Overdoses, Opioid Prescriptions, Opioids, Opioids, Opioids, Opioids, Opioids, Overdoses, Overturned Verdicts, Prescriptions, Probes, Specialty Pharma, Substance Abuse, Tennessee, Therapeutics, U.S. Opioid Crisis
Endo International plc announced that the Tennessee Court of Appeals reversed a trial court judge’s order denying a motion for recusal by Endo’s wholly owned subsidiaries Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. in Clay County et al. v. Purdue Pharma, L.P., et al, pending in the Circuit Court for Cumberland County, Tennessee, and remanded the case for transfer to a different judge.
Fentanyl overdoses are now the top cause of death among U.S. residents ages 18-45, surpassing suicide, car accidents and COVID, according to an analysis of federal data by opioid awareness organization Families Against Fentanyl. To prevent such deaths, FentCheck’s co-founders and a team of volunteers regularly visit a network of businesses in Oakland, San Francisco, New York and Philadelphia to replenish stocks of the test strips.
Biohaven Presentation at AAN Showed Decreased Opioid Use in Migraine Patients Following Nurtec® ODT Therapy: A Real-World Administrative Claims AnalysisAcute Migraine, Episodic Migraine, Hydrocodone, Migraine, Migraine Headaches, Opioid Dependence, Opioid Prescriptions, Opioid Safety, Prescriptions, R&D, Real world evidence, Research & Development, Therapeutics
Longitudinal medical and prescription claims were used to assess opioid prescriptions and MME’s dispensed amongst migraine patients nine months prior to and nine months following Nurtec® ODT initiation. Among […]
The Pandemic Has Aggravated the Opioid Crisis – Is Biden’s Plan Enough to Combat It?Addictions, CDC, Coronavirus Disease (COVID-19) Pandemic, Drug Enforcement Agency (DEA), February 2022, Fentanyl, Heroin, Issue Archives, Joe Biden, Opioid Use Disorder (OUD), Opioids, Overdose Deaths, U.S. Opioid Crisis, United States
The pandemic has undoubtedly altered the way of life for all Americans, but it has also shed light into the bleak statistics that are showing the opioid crisis is even worse than ever before. For the first time in history, the Centers for Disease Control and Prevention (CDC) reported that nearly 100,000 Americans died from drug overdoses over a 12-month period ending in March 2021, which was a little more than a 30 percent increase from the previous year.
A California judge on Nov. 1 said he would rule against several large counties that accused four drugmakers of fueling the U.S. opioid epidemic, saying they failed during a trial to prove their $50 billion case.
Ashfield Engage, part of UDG Healthcare plc, today announced that it has been selected by U.S.-based Pacira BioSciences Inc. to provide strategic commercialization services for the company’s non-opioid pain management products in select European countries. Pacira has partnered with Ashfield Engage to develop a commercial strategy and deliver outsourced operations in numerous European countries, including the UK, Germany, Sweden, Austria, the Netherlands and Finland.
The U.S. Federal Trade Commission filed a lawsuit against Endo Pharmaceuticals and Impax Laboratories that alleges a 2017 agreement eliminated competition between the companies for the pain medicine oxymorphone ER.
Addressing Spikes in Substance Use Disorder Following COVID-19 Date: Wednesday, September 23, 2020 Time: 01:00 – 02:00 PM EDT Duration: 1 Hour Register Here As communities worry about […]